US Patent Issued to CKD BIO on Feb. 3 for "Lactobacillus delbrueckii subsp. lactis CKDB001 strain, and composition for prevention, amelioration, or treatment of non-alcoholic fatty liver comprising same" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,319, issued on Feb. 3, was assigned to CKD BIO Corp. (Seoul, South Korea).

"Lactobacillus delbrueckii subsp. lactis CKDB001 strain, and composition for prevention, amelioration, or treatment of non-alcoholic fatty liver comprising same" was invented by Hyunchae Joung (Gyeonggi-do, South Korea), Byoung-Kook Kim (Seoul, South Korea), Bo Hye Heo (Gyeonggi-do, South Korea), Min Ho Seo (Gyeonggi-do, South Korea) and Woo Ri Kim (Incheon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a Lactobacillus lactis CKDB001 strain, and a composition for the prevention or treatment of non-alcoholic fatty liver comprising s...